Aristippos Gennadios, President Softgel & Oral Technology at Catalent, Inc. (CTLT), sold 930 shares at $113.05 ($105K) on 2021-07-26, disclosed to the SEC on 2021-07-28.
Seasonal sale ($105k) by President Softgel & Oral Technology — this insider has traded CTLT in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $113.05 | 465 | $53K | 50.0% |
| 2 | $113.05 | 465 | $53K | 50.0% |
| Total | $113.05 avg | 930 | $105K | 100% |
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-08-26 | $339K | — | Filing → |